Third booster dose of AstraZeneca vaccine effective against Omicron variant, claims study


London: antibody enhancement Against the Omicron version of coronavirus Increases after the third booster dose of AstraZeneca vaccinia vaccine. This was stated by the Anglo-Swedish Biopharm Company in its preliminary data released on Thursday.

The ongoing trial of the Covid-19 vaccine developed by Oxford University and administered as Covishield in India has shown that its third dose boosted the body’s immunity to beta, delta, alpha and gamma variants of SARS-COV2. is extended.

A separate analysis of test samples showed that antibodies were also rapidly formed against the omicron version of the form of the COVID-19 virus. The results were studied in people who had been vaccinated against Vaxjavaria or the mRNA vaccine.

Sir M Pangolz, Executive Vice President of Biopharmaceuticals R&D at AstraZeneca, said that Vaxgeveria has saved millions of people around the world from corona. These data suggest that it plays an important role as a third booster dose. Even when given after other vaccines.

The company said it is making these additional data available to health authorities around the world, given the urgent need for a third supplement. The third dose of Vaxgeria after initial vaccination) showed a rapid increase in antibodies.

First published:January 13, 2022, 10:03 PM

Leave a Reply